ALA 0.00% 15.5¢ arovella therapeutics limited

next 2 weeks, page-42

  1. 3,958 Posts.
    lightbulb Created with Sketch. 492
    Well if you consider success as having the price closer to the NDF research valuation of 17c then yes it has been disappointing.

    But on the flip side there has been 37m traded in the last 6 and a half days which means that roughly 3% of the register has changed hands and enabled some stale holders to exit the stock and bring in some new shareholders onto the register.

    Rising volume and rising prices is ideal, and we all hope and expect we will get there.

    But in the meantime there is a new group of people that like the story and see value at these current prices. Once the stale holders exit (and you cant blame them, all you need to do is look at the share price chart), then hopefully our path higher will be easier and can take place with lower selling pressure.

    But yes, there is an increased focus and attention on the company so any company announcement would have a greater chance of impacting the share price more so than previously.
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.